Skip to main content

Table 1 Cohort description by EHR-Berlin ARDS phenotype

From: Evaluating construct validity of computable acute respiratory distress syndrome definitions in adults hospitalized with COVID-19: an electronic health records based approach

Features

Total

ARDS-

ARDS+

P

 

N = 765

 N = 594

 N = 171

 

Demographics

    

Age, years, mean (SD)

57 (18)

57 (19)

57 (15)

0.68

Male sex, N (%)

471 (62%)

347 (58%)

124 (73%)

< 0.001

Race, N (%)

   

0.18

White

478 (62%)

372 (63%)

106 (62%)

 

Black/African American

116 (15%)

100 (17%)

16 (9%)

 

Asian

99 (13%)

80 (13%)

19 (11%)

 

American Indian or Alaskan Native

24 (3%)

18 (3%)

6 (4%)

 

Native Hawaiian/ Pacific Islander

14 (2%)

9 (2%)

5 (3%)

 

Unknown

34 (4%)

15 (3%)

19 (11%)

 

Ethnicity, N (%)

   

0.016

Not Hispanic

539 (70%)

435 (73%)

104 (61%)

 

Hispanic

176 (23%)

127 (21%)

49 (29%)

 

Unknown

50 (7%)

32 (5%)

18 (11%)

 

Chronic comorbidities

    

Diabetes, N (%)

314 (41%)

227 (38%)

87 (51%)

0.003

Chronic renal disease, N (%)

202 (26%)

157 (26%)

45 (26%)

0.98

Chronic heart failure, N (%)

199 (26%)

152 (26%)

47 (27%)

0.62

Chronic pulmonary disease, N (%)

174 (23%)

137 (23%)

37 (22%)

0.69

Illness severity at admission

    

Intensive care unit, N (%)

255 (34%)

121 (20%)

134 (79%)

< 0.001

Invasive mechanical ventilation, N (%)

144 (19%)

32 (5%)

112 (65%)

< 0.001

Noninvasive mechanical ventilation, N (%)

21 (3%)

5 (1%)

16 (9%)

< 0.001

High-flow oxygen, N (%)

42 (5%)

18 (3%)

24 (14%)

< 0.001

Resource utilization outcomes

    

Duration of invasive mechanical ventilation, days, median (IQR)

0 (0–1)

0 (0–0)

10 (3–22)

< 0.001

ICU length of stay, days, median (IQR)

0 (0–5)

0 (0–1)

13 (4–22)

< 0.001

Hospital length of stay, days, median (IQR)

8 (4–19)

6 (3–13)

19 (10–28)

< 0.001

  1. P values are for two sample t-tests for age, Wilcoxon rank-sum test for resource utilization outcomes, and Chi square tests for categorical variables